Avalo director granted 20,100 stock options
Avalo Therapeutics director Samantha Truex received a new stock option grant, not an open-market share purchase.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Avalo Therapeutics director Samantha Truex received a new stock option grant, not an open-market share purchase. She was granted options to buy 20,100 shares of Avalo Therapeutics common stock at an exercise price of $13.96 per share. These options vest 100% on the first anniversary of the grant date, contingent on her continued board service, and expire on June 2, 2036. Following this award, she holds 20,100 stock options directly, with no sales or exercises reported in this filing.
Insider Trade Summary
Grant/Award: 20,100 shares
Grant/Award
1 txn
Insider
Truex Samantha
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 20,100 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 20,100 contracts (Direct)
Footnotes (1)
- F1. The stock option vests 100% on the first anniversary of the date of grant, subject to the director's continued service on such vesting date.
Key Figures
Stock options granted: 20,100 options
Exercise price: $13.96 per share
Underlying shares: 20,100 shares
+3 more
6 metrics
Stock options granted
20,100 options
Grant to director Samantha Truex on June 2, 2026
Exercise price
$13.96 per share
Price to buy Avalo Therapeutics common stock
Underlying shares
20,100 shares
Common stock underlying the stock options
Options after transaction
20,100 options
Total derivative holdings following grant
Expiration date
June 2, 2036
Final expiration of stock options
Vesting schedule
100% after one year
Fully vests on first anniversary of grant
Key Terms
Stock Option (Right to Buy), exercise price, Common Stock, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "13.9600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vesting financial
"The stock option vests 100% on the first anniversary of the date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Avalo Therapeutics (AVTX) director Samantha Truex report on this Form 4?
She reported a grant of stock options for 20,100 shares of Avalo Therapeutics common stock. The options are a compensation award, not an open-market purchase, and give her the right to buy shares at a fixed exercise price.
How many Avalo Therapeutics (AVTX) stock options were granted to Samantha Truex?
She was granted stock options covering 20,100 shares of Avalo Therapeutics common stock. This entire amount is new derivative exposure reported in the filing and represents her total option holdings after the transaction.
What is the exercise price of Samantha Truex’s Avalo Therapeutics (AVTX) stock options?
The stock options have an exercise price of $13.96 per share. This is the fixed price at which she can purchase Avalo Therapeutics common stock if and when she exercises the options before expiration.
When do Samantha Truex’s Avalo Therapeutics (AVTX) stock options vest?
The options vest 100% on the first anniversary of the grant date. Vesting is conditioned on her continued service as a director through that vesting date, according to the footnote disclosure.
When do the newly granted Avalo Therapeutics (AVTX) stock options expire?
The stock options expire on June 2, 2036. If they are not exercised by that expiration date, her right to buy Avalo Therapeutics common stock at the $13.96 exercise price will lapse.
AI-generated analysis. How Rhea-AI works. Not financial advice.
